Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Role of Antibody and Complement in the Immune Clearance and Destruction of Erythrocytes I. IN VIVO EFFECTS OF IgG AND IgM COMPLEMENT-FIXING SITES
Aland D. Schreiber, Michael M. Frank
Aland D. Schreiber, Michael M. Frank
Published March 1, 1972
Citation Information: J Clin Invest. 1972;51(3):575-582. https://doi.org/10.1172/JCI106846.
View: Text | PDF
Research Article Article has an altmetric score of 6

Role of Antibody and Complement in the Immune Clearance and Destruction of Erythrocytes I. IN VIVO EFFECTS OF IgG AND IgM COMPLEMENT-FIXING SITES

  • Text
  • PDF
Abstract

A model which permits evaluation in molecular terms of the role of antibody and of complement in the immune destruction of erythrocytes was established in the guinea pig. IgM and IgG immunoglobulins were isolated from rabbit anti-guinea pig erythrocyte antisera and were used to sensitize 51Cr-labeled guinea pig erythrocytes. The average number of complement-fixing sites per erythrocyte formed by antibody was determined for each of the various preparations by the Cla fixation and transfer test. The rate of clearance and of organ localization was determined for cells sensitized with either IgM or IgG antibodies, and dose-response curves were established in normal guinea pigs and guinea pigs with a genetically controlled, complete absence of the fourth component of complement (C4).

Authors

Aland D. Schreiber, Michael M. Frank

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1969 Total
Citations: 1 4 3 5 6 1 2 6 4 3 7 3 5 4 5 3 3 3 3 4 6 4 3 5 2 2 3 3 4 5 2 4 2 5 8 4 4 4 6 9 6 8 3 2 4 1 5 3 5 1 1 199
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (199)

Title and authors Publication Year
FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis
Lindorfer MA, Taylor RP
Antibodies 2022
Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion
M Borsky, V Hrabcakova, J Novotna, Y Brychtova, M Doubek, A Panovska, P Muller, J Mayer, M Trbusek, M Mraz
Leukemia Research 2021
Anti‐JMH alloantibody in inherited JMH‐negative patients leads to immunogenic destruction of JMH‐positive RBCs
Z Yuan, Y Wei, X Chen, S He, K Cai, M Zhong, H Huang, X Tong, Z Liu, X Yang
Clinical & Experimental Immunology 2021
Immunohematological and Clinical Characterization of Complement and Non-Complement Associated Warm Autoimmune Haemolytic Anemia and Risk Factors Predicting their Occurrences
SS Das, A Chakrapani, S Bhattacharya, RN Biswas, M Safi
Indian Journal of Hematology and Blood Transfusion 2021
Halting targeted and collateral damage to red blood cells by the complement system
M Jalink, EC de Boer, D Evers, MQ Havinga, JM Vos, S Zeerleder, M de Haas, I Jongerius
Seminars in Immunopathology 2021
Complement Activation in the Treatment of B-Cell Malignancies
CS Zent, JJ Pinney, CC Chu, MR Elliott
Antibodies 2020
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
J Golay, RP Taylor
Antibodies 2020
Streptococci and the complement system: interplay during infection, inflammation and autoimmunity
S Syed, L Viazmina, R Mager, S Meri, K Haapasalo
FEBS Letters 2020
Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions
CM Arthur, S Chonat, R Fasano, ME Yee, CD Josephson, JD Roback, SR Stowell
Transfusion Medicine Reviews 2019

Cold agglutinin disease: current challenges and future prospects


S Berentsen, A Röth, U Randen, B Jilma, GE Tjønnfjord
Journal of blood medicine 2019
Novel insights into the treatment of complement-mediated hemolytic anemias
S Berentsen, A Hill, QA Hill, TH Tvedt, M Michel
Therapeutic Advances in Hematology 2019
Reexamination of the chromium‐51–labeled posttransfusion red blood cell recovery method
RO Francis, S Mahajan, F Rapido, FL Carpia, M Soffing, C Divgi, R Yeh, A Mintz, L Leslie, I Agrest, MS Karafin, Y Ginzburg, BH Shaz, SL Spitalnik, J Schwartz, T Thomas, X Fu, P Amireault, P Buffet, JC Zimring, A D'Alessandro, EA Hod
Transfusion 2019
Role of complement in patients with autoimmune hemolytic anemia and platelet transfusion refractoriness
MJ Fontaine
Transfusion Clinique et Biologique 2019
C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice
SN Syed, E Rau, M Ziegelmann, G Sogkas, B Brüne, RE Schmidt
European Journal of Immunology 2018
Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen
A Mener, CM Arthur, SR Patel, J Liu, JE Hendrickson, SR Stowell
Frontiers in immunology 2018
Accommodation in ABO-incompatible organ transplants
MG de Mattos Barbosa, M Cascalho, JL Platt
Xenotransplantation 2018
Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease
S Berentsen
Seminars in Hematology 2018
How I manage patients with cold agglutinin disease
S Berentsen
British Journal of Haematology 2018
Immune Hematology
JM Despotovic
2018
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
CH Lee, G Romain, W Yan, M Watanabe, W Charab, B Todorova, J Lee, K Triplett, M Donkor, OI Lungu, A Lux, N Marshall, MA Lindorfer, OR Goff, B Balbino, TH Kang, H Tanno, G Delidakis, C Alford, RP Taylor, F Nimmerjahn, N Varadarajan, P Bruhns, YJ Zhang, G Georgiou
Nature Immunology 2017
Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
RP Taylor, MA Lindorfer
Seminars in Immunology 2016
Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future
AM Risitano, S Marotta
Seminars in Immunology 2016
Pathobiology of Transfusion Reactions
JC Zimring, SL Spitalnik
Annual review of pathology 2015
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages: Antibody-dependent phagocytosis in CLL
AK Church, KR VanDerMeid, NA Baig, AM Baran, TE Witzig, GS Nowakowski, CS Zent
Clinical & Experimental Immunology 2015
Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
S Berentsen, T Sundic
BioMed Research International 2015
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
T Shimizu, Y Mima, Y Hashimoto, M Ukawa, H Ando, H Kiwada, T Ishida
Immunobiology 2015
Role of Complement in Autoimmune Hemolytic Anemia
S Berentsen
Transfusion Medicine and Hemotherapy 2015
Autoimmune Hemolysis: A Journey through Time
J Freedman
Transfusion Medicine and Hemotherapy 2015
Analyses of CD20 Monoclonal Antibody-Mediated Tumor Cell Killing Mechanisms: Rational Design of Dosing Strategies
RP Taylor, MA Lindorfer
Molecular pharmacology 2014
Antibody Fc
MA Lindorfer, J Köhl, RP Taylor
Antibody Fc 2014
Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia
NA Baig, RP Taylor, MA Lindorfer, AK Church, BR LaPlant, AM Pettinger, TD Shanafelt, GS Nowakowski, CS Zent
Journal of immunology (Baltimore, Md. : 1950) 2014
Handbook of Therapeutic Antibodies: Dübel/Handbook of Therapeutic Antibodies
P Ward, M Bodmer
Handbook of Therapeutic Antibodies: Dübel/Handbook of Therapeutic Antibodies 2014
Dubois' Lupus Erythematosus and Related Syndromes
JC Crispín, GC Tsokos
Dubois' Lupus Erythematosus and Related Syndromes 2013
The role of complement in mAb-based therapies of cancer
RP Taylor, MA Lindorfer
Methods 2013
Evaluation of diagnostic assays for the serological detection of Actinobacillus pleuropneumoniae on samples of known or unknown exposure
T Opriessnig, M Hemann, JK Johnson, S Heinen, LG Giménez-Lirola, KC ONeill, H Hoang, KJ Yoon, M Gottschalk, PG Halbur
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2013
Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model
JS Liepkalns, EA Hod, SR Stowell, CM Cadwell, SL Spitalnik, JC Zimring
Transfusion 2012
Exhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients
FJ Beurskens, MA Lindorfer, M Farooqui, PV Beum, P Engelberts, WJ Mackus, PW Parren, A Wiestner, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2012
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer
M Elvington, Y Huang, BP Morgan, F Qiao, N Rooijen, C Atkinson, S Tomlinson
Blood 2012
Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
SR Stowell, AM Winkler, CL Maier, CM Arthur, NH Smith, KR Girard-Pierce, RD Cummings, JC Zimring, JE Hendrickson
Clinical and Developmental Immunology 2012
A model for lupus brain disease: Antibody to NMDA receptor in SLE
B Diamond, BT Volpe
Immunological Reviews 2012
Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion
JS Liepkalns, CM Cadwell, SR Stowell, EA Hod, SL Spitalnik, JC Zimring
Transfusion 2012
Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?
MA Lindorfer, A Wiestner, CS Zent, RP Taylor
OncoImmunology 2012
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Cellular Hematology
SU Monrad, MJ Kaplan
Systemic Lupus Erythematosus 2011
Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
PV Beum, EM Peek, MA Lindorfer, FJ Beurskens, PJ Engelberts, PW Parren, JG van de Winkel, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2011
Antibodies to actin in autoimmune haemolytic anaemia
KM Felder, K Hoelzle, K Heinritzi, M Ritzmann, LE Hoelzle
BMC veterinary research 2010
Use of mouse models to study the mechanisms and consequences of RBC clearance
EA Hod, SA Arinsburg, RO Francis, JE Hendrickson, JC Zimring, SL Spitalnik
Vox Sanguinis 2010
The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis
M Allhorn, JG Briceño, L Baudino, C Lood, ML Olsson, S Izui, M Collin
Blood 2010
Antigenic modulation and rituximab resistance
RP Taylor, MA Lindorfer
Seminars in Hematology 2010
Transfusionsmedizin und Immunhämatologie
V Kiefel, C Mueller-Eckhardt
2010
Clinical application of a flow cytometric direct antiglobulin test
JS Lin, TC Hao, JY Lyou, YJ Chen, HM Liu, CH Tzeng, TJ Chiou
Transfusion 2009
Enhancing the Action of Rituximab in Chronic Lymphocytic Leukemia by Adding Fresh Frozen Plasma
A Klepfish, L Gilles, K Ioannis, R Eliezer, S Ami
Annals of the New York Academy of Sciences 2009
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia
G Aue, MA Lindorfer, PV Beum, AW Pawluczkowycz, B Vire, T Hughes, RP Taylor, A Wiestner
Haematologica 2009
An engineered complement receptor 1 composed of two functional domains can protect against immune-mediated hemolysis
Y Yang, L He, B Tan, G Liu, Z Wang
Protein Expression and Purification 2009
Lessons learned from mouse models of hemolytic transfusion reactions
EA Hod, JC Zimring, SL Spitalnik
Current Opinion in Hematology 2008
Hemolytic anemia due to warm autoantibodies
CH Packman
Blood Reviews 2008
Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura
PG Rubinstein, YH Chen
American Journal of Hematology 2008
Within Peripheral Blood Mononuclear Cells, Antibody-Dependent Cellular Cytotoxicity of Rituximab-Opsonized Daudi cells Is Promoted by NK Cells and Inhibited by Monocytes due to Shaving
PV Beum, MA Lindorfer, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2008
Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to Cancer Cells Promotes Trogocytosis Mediated by THP-1 Cells and Monocytes
PV Beum, DA Mack, AW Pawluczkowycz, MA Lindorfer, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2008
Mechanisms of killing by anti-CD20 monoclonal antibodies
MJ Glennie, RR French, MS Cragg, RP Taylor
Molecular Immunology 2007
Rituximab-CD20 Complexes Are Shaved from Z138 Mantle Cell Lymphoma Cells in Intravenous and Subcutaneous SCID Mouse Models
Y Li, ME Williams, JB Cousar, AW Pawluczkowycz, MA Lindorfer, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2007
Blood Banking and Transfusion Medicine
JM Fisk, PT Pisciotto, EL Snyder, PL Perrotta
Blood Banking and Transfusion Medicine 2007
Cellular derived anaphylatoxins as key mediators of antibody dependent type II autoimmunity in mice
Varsha Kumar, Syed R. Ali, Stephanie Konrad, Jörg Zwirner, J. Sjef Verbeek, Reinhold E. Schmidt, J. Engelbert Gessner
Journal of Clinical Investigation 2006
Mouse models of IgG- and IgM-mediated hemolysis
DA Schirmer, SC Song, JP Baliff, SO Harbers, RA Clynes, A Krop-Watorek, GR Halverson, M Czerwinski, SL Spitalnik
Blood 2006
The Autoimmune Diseases
I Kang, J Craft
The Autoimmune Diseases 2006
Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus
CC Liu, S Manzi, AH Kao, JS Navratil, MJ Ruffing, JM Ahearn
Arthritis & Rheumatism 2005
Characterization of complement receptor 1 domains for prevention of complement-mediated red cell destruction
A Mqadmi, Y Abdullah, K Yazdanbakhsh
Transfusion 2005
Processing of C3b-Opsonized Immune Complexes Bound to Non-Complement Receptor 1 (CR1) Sites on Red Cells: Phagocytosis, Transfer, and Associations with CR1
ML Craig, JN Waitumbi, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2005
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia
AD Kennedy, PV Beum, MD Solga, DJ DiLillo, MA Lindorfer, CE Hess, JJ Densmore, ME Williams, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2004
Prevention of complement-mediated immune hemolysis by a small molecule compound
A Mqadmi, X Zheng, J Song, S Abramowitz, P Giclas, K Yazdanbakhsh
Biochemical and Biophysical Research Communications 2004
Transfusionsmedizin
C Mueller-Eckhardt, V Kiefel
Transfusionsmedizin - Immunhämatologie Hämotherapie Immungenetik Zelltherapie 2004
Treatment with megestrol acetate improves human immunodeficiency virus-associated immune thrombocytopenia
F Gomez, P Ruiz, R Lopez, C Rivera
Clinical and diagnostic laboratory immunology 2002
Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody
SA da Silveira, S Kikuchi, L Fossati-Jimack, T Moll, T Saito, JS Verbeek, M Botto, MJ Walport, M Carroll, S Izui
Journal of Experimental Medicine 2002
The Complete Spleen
AJ Bowdler
2002
Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF
H Molina, T Miwa, L Zhou, B Hilliard, D Mastellos, MA Maldonado, JD Lambris, WC Song
Blood 2002
Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia
S Izui, L Fossati-Jimack, SA da Silveira, T Moll
Springer Seminars in Immunopathology 2001
Cd47-Signal Regulatory Protein   (Sirp ) Regulates Fc  and Complement Receptor-Mediated Phagocytosis
PA Oldenborg, HD Gresham, FP Lindberg
Journal of Experimental Medicine 2001
CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis
PA Oldenborg, HD Gresham, FP Lindberg
Journal of Experimental Medicine 2001
Fcγ-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-α levels
ML Refici, DW Metzger, BP Arulanandam, MR Lennartz, DJ Loegering
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2001
Enhancement of Splenic-Macrophage Fcγ Receptor Expression by Treatment with Estrogens
F Gomez, P Ruiz, JA Bernal, M Escobar, A Garcia-Egido, JJ Lopez-Saez
2001
Immunology, Immunopathology, and Immunity
S Sell
2001
Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan
J Yan, V Větvička, Y Xia, M Hanikýřová, TN Mayadas, GD Ross
Immunopharmacology 2000
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
A Sahu, JD Lambris
Immunopharmacology 2000
Effects of Androgen Treatment on Expression of Macrophage Fcγ Receptors
F Gomez, P Ruiz, R Lopez, C Rivera, S Romero, JA Bernal
2000
Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.
Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S
Journal of Experimental Medicine 2000
Reduction of myocardial infarct size with sCR1sLex, an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x
K Zacharowski, M Otto, G Hafner, HC Marsh, C Thiemermann
British Journal of Pharmacology 1999
How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
A Nardin, MA Lindorfer, RP Taylor
Molecular Immunology 1999
Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs
F Gomez, P Ruiz, F Briceño, C Rivera, R Lopez
Clinical Immunology 1999
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16)
L Fossati-Jimack, A Ioan-Facsinay, L Reininger, Y Chicheportiche, N Watanabe, T Saito, FM Hofhuis, JE Gessner, C Schiller, RE Schmidt, T Honjo, JS Verbeek, S Izui
Journal of immunology (Baltimore, Md. : 1950) 1998
The Human Complement System in Health and Disease
J Ahearn, A Rosengard
The Human Complement System in Health and Disease 1998
Treatment with Progesterone Analogues Decreases Macrophage Fcγ Receptors Expression
F Gomez, P Ruiz, F Briceño, R Lopez, A Michan
Clinical Immunology and Immunopathology 1998
Encyclopedia of Immunology
RL Riley
Encyclopedia of Immunology 1998
New Diagnostic Methods in Oncology and Hematology
D Huhn
1998
Human intravenous immunoglobulin therapy
J Catharine, R Scott-Moncrieff, WJ Reagan
Seminars in Veterinary Medicine and Surgery Small Animal 1997
The Primate Erythrocyte Complement Receptor (CR1) as a Privileged Site: Binding of Immunoglobulin G to Erythrocyte CR1 Does Not Target Erythrocytes for Phagocytosis
ML Reinagel, M Gezen, PJ Ferguson, S Kuhn, EN Martin, RP Taylor
Blood 1997
PERIPHERAL XENOGENEIC IMMUNOLOGICAL RESPONSE TO ENCAPSULATED BOVINE ADRENAL CHROMAFFIN CELLS IMPLANTED WITHIN THE SHEEP LUMBAR INTRATHECAL SPACE:
FA Kaplan, PM Krueger, J Harvey, MB Goddard
Transplantation 1996
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
D Sylvestre, R Clynes, M Ma, H Warren, MC Carroll, JV Ravetch
Journal of Experimental Medicine 1996
Blood group A immunodeterminants on human red cells differ in biologic activity and sensitivity to alpha-N-acetylgalactosaminidase
LC Hoskins, G Larson, GB Naff
Transfusion 1995
Cytotoxic antibodies trigger inflammation through Fc receptors
R Clynes, JV Ravetch
Immunity 1995
In vitro assays to predict the severity of hemolytic disease of the newborn
AG Hadley
Transfusion Medicine Reviews 1995
IgG-mediated phagocytosis in regenerated splenic tissue
MT Clayer, PA Drew, AS Leong, GG Jamieson
Clinical & Experimental Immunology 1994
Impaired Function of Macrophage Fcγ Receptors and Bacterial Infection in Alcoholic Cirrhosis
F Gomez, P Ruiz, AD Schreiber
New England Journal of Medicine 1994
Transfusion Therapy in Autoimmune Hemolytic Anemia
LC Jefferies
Hematology/Oncology Clinics of North America 1994
Complement-dependent synergistic effects of rat monoclonal IgG antibodiesin vivo
N Yousaf, JC Howard, BD Williams
European Journal of Immunology 1993
Corticosteroids as Immunomodulators
HN Claman
Annals of the New York Academy of Sciences 1993
Alloantibodies against A and B blood types in cats
J Bücheler, U Giger
Veterinary Immunology and Immunopathology 1993
5 The role of Rh antibodies in haemolytic disease of the newborn
AG Hadley, BM Kumpel
Baillière's Clinical Haematology 1993
Is there a mechanical factor of haemolysis in patients with positive IgG-type direct antiglobulin test?
M Delamaire, F Durand, B Grosbois, G Dantec, C Dauriac, MC Goff, R Blay, B Genetet
British Journal of Haematology 1992
In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD
BJ Pereira, DD Poutsiaka, AJ King, JA Strom, G Narayan, AS Levey, CA Dinarello
Kidney International 1992
New aspects of IvIgG treatment in immune hemocytopenias
P Berchtold
Transfusion Science 1992
The Complement System
A Agostoni, M Cicardi, M Gardinali, L Bergamaschini
International journal of immunopathology and pharmacology 1992
Mononuclear Phagocytes
R van Furth
1992
In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc gamma receptors
P Ruiz, F Gomez, M King, R Lopez, C Darby, AD Schreiber
Journal of Clinical Investigation 1991
Effect of cyclophosphamide on the clearance of IgG-sensitized red cells in mice
MS Palermo, M Giordano, MA Isturiz
Clinical Immunology and Immunopathology 1991
Impaired Function of Macrophage Fc<sub>γ</sub> Receptors in End-Stage Renal Disease
P Ruiz, F Gomez, AD Schreiber
New England Journal of Medicine 1990
Existe-t-il un mécanisme physique d'hémolyse chez les patients porteurs d'une anémie hémolytique autoimmune?
M Delamaire, F Durand, GL Dantec, B Grosbois, C Dauriac, MC Goff, RL Blay, B Genetet
La Revue de Médecine Interne 1990
Corticosteroid therapy in rheumatoid arthritis
E George, JR Kirwan
Baillière's Clinical Rheumatology 1990
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
HF Weisman, T Bartow, MK Leppo, HC Marsh, GR Carson, MF Concino, MP Boyle, KH Roux, ML Weisfeldt, DT Fearon
Science 1990
Dysfunction of the mononuclear phagocytic system in sepsis
J Gutiérrez-Fernåndez, MC Maroto, G Piédrola, E Zamora
APMIS 1989
Demonstration of hepatic Fc receptor function in vivo
N Yousaf, JC Howard, BD Williams
Clinical & Experimental Immunology 1989
Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3
BL Myones, JG Dalzell, N Hogg, GD Ross
Journal of Clinical Investigation 1988
Studies in the rat of antibody-sensitized and N-ethylmaleimide-treated erythrocyte clearance by the liver: effects of immune complex infusion and complement activation
N Yousaf, JC Howard, BD Williams
Immunology 1988
Differing complement-mediated opsonic activity of rabbit interstitial fluids from autologous serum
C Lam, A Georgopoulos, E Schütze
Comparative Immunology, Microbiology and Infectious Diseases 1988
Mechanisms of Physical and Emotional Stress
GP Chrousos, DL Loriaux, PW Gold
1988
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988
Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome
BS Bender, JF Bohnsack, SH Sourlis, MM Frank, TC Quinn
Journal of Clinical Investigation 1987
An Autoantibody with Activity Dependent on Red Cell Age in the Serum of a Patient with Autoimmune Haemolytic Anaemia and a Negative Direct Antiglobulin Test
R Herron, M Clark, DS Smith
Vox Sanguinis 1987
The Significance of Complement on the Red Cell Surface
J Freedman
Transfusion Medicine Reviews 1987
The interaction of antibody/dna immune complexes with complement
RP Taylor, JC Edberg, GA Kujala, AJ Sloman, CC Wilson, ME Cronin
Arthritis & Rheumatism 1987
The complement fragment C3d facilitates phagocytosis by monocytes
TA Gaither, I Vargas, S Inada, MM Frank
Immunology 1987
A receptor for monomeric IgG2b on rat macrophages
S Denham, R Barfoot, E Jackson
Immunology 1987
Autoantibodies to erythrocytes
LE Silberstein, S Spitalnik
Clinical Immunology Newsletter 1987
Lymphokines
HM Johnson, BA Torres
Lymphokines 1987
Pathophysiology of hemolysis in infections with Hemophilus influenzae type b
SB Shurin, P Anderson, J Zollinger, RK Rathbun
Journal of Clinical Investigation 1986
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody
SB Clarkson, RP Kimberly, JE Valinsky, MD Witmer, JB Bussel, RL Nachman, JC Unkeless
Journal of Experimental Medicine 1986
Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo
R Veerhuis, MC Krol, LA van Es, MR Daha
Clinical Immunology and Immunopathology 1986
The Reticuloendothelial System
H Friedman, MR Escobar, SM Reichard, SM Phillips
1986
Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes
D Friedman, F Netti, AD Schreiber
Journal of Clinical Investigation 1985
Platelet antibodies of the IgM class in immune thrombocytopenic purpura
DB Cines, SB Wilson, A Tomaski, AD Schreiber
Journal of Clinical Investigation 1985
Complement-activating antineutrophil antibody in systemic lupus erythematosus
PK Rustagi, MS Currie, GL Logue
The American Journal of Medicine 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease
CJ Parker, CM Soldato, MJ Telen
Journal of Clinical Investigation 1984
Erythrocyte sensitization with monomeric IgM in a patient with hemolytic anemia
IO Szymanski, SR Huff, LG Selbovitz, GK Sherwood
American Journal of Hematology 1984
The Significance of Complement in Immunohematology
G Garratty, EA Stcane
Critical Reviews in Clinical Laboratory Sciences 1984
Diseases of the Lymphatic System
DW Molander
1984
Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro
EJ Brown, KA Joiner, MM Frank
Journal of Clinical Investigation 1983
Differential binding of IgG anti-D and IgG autoantibodies to reticulocytes and red blood cells
LS Gray, JE Kleeman, SP Masouredis
British Journal of Haematology 1983
Complement (C3) binding to platelets in autoimmune thrombocytopenia
LM Kernoff, E Malan
Clinical & Laboratory Haematology 1983
The effect of complement-depletion or mannosyl receptor blockade on the in vivo clearance of antigen during a primary immune response in rabbits
GD Harkiss, DL Brown
British Journal of Experimental Pathology 1983
Immune Mechanisms in Renal Disease
NB Cummings, AF Michael, CB Wilson
1983
Surgery of the Spleen
A Mitchell, PJ Morris
Clinics in Haematology 1983
A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia
EJ Brown, SW Hosea, CH Hammer, CG Burch, MM Frank
Journal of Clinical Investigation 1982
Activation of human complement by immunoglobulin G antigranulocyte antibody
PK Rustagi, MS Currie, GL Logue
Journal of Clinical Investigation 1982
Immunpharmakologie der Kortikosteroide
LH Block, W Vetter, W Siegenthaler
Klinische Wochenschrift 1982
C-REACTIVE PROTEIN REACTIVITY WITH COMPLEMENT AND EFFECTS ON PHAGOCYTOSIS
C Mold, TW du Clos, S Nakayama, KM Edwards, H Gewurz
Annals of the New York Academy of Sciences 1982
Murine malaria: blood clearance and organ sequestration of Plasmodium yoelii-infected erythrocytes
LP Smith, KW Hunter, EC Oldfield, GT Strickland
Infection and immunity 1982
The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages
MR Daha, LA van Es
Immunology 1982
An improved method for performance of the C1 fixation and transfer test
EJ Brown
Journal of Immunological Methods 1982
Alteration by protein A of the distribution of immune complexes containing antigen of retrovirus
WM Siag, JM Jones
Clinical Immunology and Immunopathology 1982
Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma Globulin
J Fehr, V Hofmann, U Rappeler
New England Journal of Medicine 1982
Clearance of sensitized erythrocytes in NZB/NZW mice Effects of castration and sex hormone treatment
HL Shear, JR Roubinian, P Gil, N Talal
European Journal of Immunology 1981
Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits
GD Harkiss, DL Brown
Immunology 1981
Characterization of macrophage functions in mice infected with Brucella abortus
JR Birmingham, EL Jeska
Infection and immunity 1981
Suppression of the anti-erythrocyte immune response in mice by the C5b--9 complex of complement
W Horn, W Opferkuch, ER Podack
Immunology 1981
The effects of corticosteroids on IgG Fc receptor and complement receptor-mediated interaction of monocytes with red cells
RJ Kurlander
Clinical Immunology and Immunopathology 1981
Anemias Associated With Blood Loss and Hemolysis
BF Feldman
Veterinary Clinics of North America Small Animal Practice 1981
Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G
RJ Kurlander
Journal of Clinical Investigation 1980
Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages
FM Griffin
Journal of Experimental Medicine 1980
Characterization and measurement of normal platelet-associated immunoglobulin G by fluorospectrophotometry
K Sugiura, M Steiner, M Baldini
Biochimica et Biophysica Acta (BBA) - General Subjects 1980
Heparin-Associated Thrombocytopenia
DB Cines, P Kaywin, M Bina, A Tomaski, AD Schreiber
New England Journal of Medicine 1980
Autoimmune Hemolytic Anemia
AD Schreiber
Pediatric Clinics of North America 1980
Biochemistry and Metabolism
AJ Sbarra, RR Strauss
1980
The selective hepatic uptake of desialylated peripheral blood mononuclear cells in rabbits
CJ Steer, SP James, JM Vierling, SW Hosea, EA Jones
Gastroenterology 1980
Role of Kupffer Cells, Complement, and Specific Antibody in Bactericidal Activities of Perfused Livers
RL Friedman, RJ Moon
Infection and immunity 1980
Decreased Heat-Labile Opsonic Activity and Complement Levels Associated with Evidence of C3 Breakdown Products in Infected Pleural Effusions
PD Lew, R Zubler, P Vaudaux, JJ Farquet, FA Waldvogel, PH Lambert
Journal of Clinical Investigation 1979
Augmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T-lymphocyte product that enhances macrophage complement receptor function
JA Griffin, FM Griffin
Journal of Experimental Medicine 1979
The Characterization and Functional Significance of Plasma Membrane fc Receptors
SH Zuckerman, SD Douglas, JM Kehoe
Critical Reviews in Microbiology 1979
Cellular requirements for the formation of EA rosettes by human monocytes
JH Passwell, E Schneeberger, E Merler
Immunology 1978
On the precedence of 19S antibodies in the early immune response
AG Osler
Immunochemistry 1978
Phagocytosis. Clinical disorders of recognition and ingestion
TP Stossel
The American Journal of Pathology 1977
Pathogenesis of hemolysis in immune hemolytic anemia
JR Cohen
The Western journal of medicine 1977
Low-Titer Cold-Hemagglutinin Disease: Mechanism of Hemolysis and Response to Corticosteroids
AD Schreiber, BS Herskovitz, M Goldwein
New England Journal of Medicine 1977
Biological Amplification Systems in Immunology
NK Day, RA Good
1977
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man
CJ Jaffe, JP Atkinson, MM Frank
Journal of Clinical Investigation 1976
Alteration of human erythrocyte membrane properties by complement fixation
JR Durocher, JP Gockerman, ME Conrad
Journal of Clinical Investigation 1975
Effect of corticosteroids on the human monocyte IgG and complement receptors
AD Schreiber, J Parsons, P McDermott, RA Cooper
Journal of Clinical Investigation 1975
Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation
C Bianco, FM Griffin, SC Silverstein
Journal of Experimental Medicine 1975
Complement inclinical medicine
MM Frank, JP Atkinson
Disease-a-Month 1975
Immunogenetics and Immunodeficiency
B Benacerraf
1975
The Effect of Bacillus Calmette-Guerin-Induced Macrophage Activation on the In Vivo Clearance of Sensitized Erythrocytes
JP Atkinson, MM Frank
Journal of Clinical Investigation 1974
Studies on the In Vivo Effects of Antibody INTERACTION OF IgM ANTIBODY AND COMPLEMENT IN THE IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN
JP Atkinson, MM Frank
Journal of Clinical Investigation 1974
A human leukemia cell with both B and T cell surface receptors
E Shevach, R Edelson, M Frank, M Lutzner, I Green
Proceedings of the National Academy of Sciences 1974
Effects of Corticosteroids and Splenectomy on the Immune Clearance and Destruction of Erythrocytes
JP Atkinson, AD Schreiber, MM Frank
Journal of Clinical Investigation 1973
THE IMMUNE INTERACTION BETWEEN RED CELLS AND LEUCOCYTES AND THE PATHOGENESIS OF SPHEROCYTOSIS
DL Brown
British Journal of Haematology 1973
Macrophage-lymphocyte interaction. I. Characteristics of the antigen-independent-binding of guinea pig thymocytes and lymphocytes to syngeneic macrophages
PE Lipsky, AS Rosenthal
Journal of Experimental Medicine 1973
Generation of chemotactic factors in guinea pig serum via activation of the classical and alternate complement pathways
RA Clark, MM Frank, HR Kimball
Clinical Immunology and Immunopathology 1973
Contemporary Topics in Molecular Immunology
RA Reisfeld, WJ Mandy
1973
Role of Antibody and Complement in the Immune Clearance and Destruction of Erythrocytes I. IN VIVO EFFECTS OF IgG AND IgM COMPLEMENT-FIXING SITES
AD Schreiber, MM Frank
Journal of Clinical Investigation 1972
Protides of the Biological Fluids
PA Small, RH Waldman
Protides of the Biological Fluids 1969

← Previous 1 2 3 4 5 6 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
19 readers on Mendeley
See more details